share_log

HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Lowers Price Target to $36

HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Lowers Price Target to $36

HC Wainwright & Co.維持對格林威治生命科學的買入,將目標股價下調至36美元
Benzinga ·  02/20 07:47

HC Wainwright & Co. analyst Yi Chen maintains Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and lowers the price target from $38 to $36.

HC Wainwright & Co. 分析師陳毅維持格林威治生命科學(納斯達克股票代碼:GLSI)的買入並將目標股價從38美元下調至36美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論